Literature DB >> 17053322

Treatment of rabbit growth plate injuries with an autologous tissue-engineered composite. An experimental study.

Xiao-bing Jin1, Zhuo-jing Luo, Jing Wang.   

Abstract

Tissue engineering has become a promising way of treating growth plate injuries. In this study, we attempted investigating the role of the autologous tissue-engineered composite in the treatment of rabbit growth plate injuries. Growth plate chondrocytes from iliac crest epiphyseal cartilage of immature New Zealand rabbits were obtained by dissection and sequential digestion with 0.2% collagenase (type II). After proliferating in monolayer culture in vitro for 3 weeks, the cells were harvested and seeded onto the demineralized bone matrix (DBM) scaffold to construct the composite. The autologous tissue-engineered composites were finally implanted into the proximal right tibia defects of the growth plate created in 12 rabbits (group A underwent the operation after obtaining chondrocytes 3 weeks beforehand), another 12 rabbits were implanted with only the DBM scaffold (group B), and the defects in group C (12 rabbits) were not implanted. The left tibias of all animals were left undone as the normal control. Two weeks after the operation, severe shortness and angulation deformity of the right tibia evaluated by X-ray were gradually observed in groups B and C. However, there were no obvious changes in group A and there were significant differences between group A and groups B and C (p < 0.05) at the 4-, 8-, and 16-weeks time points. 16 weeks after operation, histological examination revealed that the defects of the right tibias in group A had restored to almost the normal columnar structure of the growth plate. The results demonstrate that tissue-engineered composite established by combination of autologous growth plate chondrocytes and DBM can prevent the formation of a bone bridge and restore the growth of damaged growth plate. 2006 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2006        PMID: 17053322     DOI: 10.1159/000095510

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  6 in total

1.  Rabbit Model of Physeal Injury for the Evaluation of Regenerative Medicine Approaches.

Authors:  Yangyi Yu; Francisco Rodriguez-Fontan; Kevin Eckstein; Archish Muralidharan; Asais Camila Uzcategui; Joseph R Fuchs; Shane Weatherford; Christopher B Erickson; Stephanie J Bryant; Virginia L Ferguson; Nancy Hadley Miller; Guangheng Li; Karin A Payne
Journal:  Tissue Eng Part C Methods       Date:  2019-10-31       Impact factor: 3.056

2.  A 3D printed mimetic composite for the treatment of growth plate injuries in a rabbit model.

Authors:  Yangyi Yu; Kristine M Fischenich; Sarah A Schoonraad; Shane Weatherford; Asais Camila Uzcategui; Kevin Eckstein; Archish Muralidharan; Victor Crespo-Cuevas; Francisco Rodriguez-Fontan; Jason P Killgore; Guangheng Li; Robert R McLeod; Nancy Hadley Miller; Virginia L Ferguson; Stephanie J Bryant; Karin A Payne
Journal:  NPJ Regen Med       Date:  2022-10-19

3.  Treatment of rabbit growth plate injuries with oriented ECM scaffold and autologous BMSCs.

Authors:  Wenchao Li; Ruijiang Xu; Jiangxiang Huang; Xing Bao; Bin Zhao
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

Review 4.  Roles of Chondroitin Sulfate Proteoglycans as Regulators of Skeletal Development.

Authors:  Nancy B Schwartz; Miriam S Domowicz
Journal:  Front Cell Dev Biol       Date:  2022-04-08

Review 5.  Enlightenment of Growth Plate Regeneration Based on Cartilage Repair Theory: A Review.

Authors:  Xianggang Wang; Zuhao Li; Chenyu Wang; Haotian Bai; Zhonghan Wang; Yuzhe Liu; Yirui Bao; Ming Ren; He Liu; Jincheng Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-06-03

6.  Chondrocyte source for cartilage regeneration in an immature animal: Is iliac apophysis a good alternative?

Authors:  Karthikeyan Rajagopal; Vivek Dutt; A Soosai Manickam; Vrisha Madhuri
Journal:  Indian J Orthop       Date:  2012-07       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.